AXIVITE
LIVE

Serial Number

79351488

Owner

aXichem AB

Attorney

Scott E. Rogers

Filing Date

Sep 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AXIVITE Trademark

Serial Number: 79351488 • Registration: 7470069

AXIVITE is a trademark filed by aXichem AB on September 5, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

aXichem AB (4 trademarks)

Södergatan 26

Entity Type: 64

Trademark Details

Filing Date

September 5, 2022

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Chemical reagents for industrial and scientific purposes, other than for medical or veterinary purposes; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical additives for use in the manufacture of food, namely, for use in and preserving of foodstuffs and fodder; chemical substances for use in marine industry, namely, substances for use in controlling and preventing clogging or fouling of organics

Chemical preparations for medical, pharmaceutical or veterinary purposes, namely, for the treatment or prevention of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vermin destroying preparations; fungicides; herbicides; nutritional supplements; pharmaceutical preparations and products for the prevention of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceuticals for the treatment of lifestyle acquired health problems, namely, metabolic, cardiovascular, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Scientific and technological services, namely, research and design in the field of biotechnology; industrial analysis and research services in the field of biotechnology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 21, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 1, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jun 11, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 22, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 25, 2024 OPNX
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 13, 2024 RFRR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 6, 2024 OPNR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 22, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jul 27, 2023 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 22, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 21, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 14, 2022 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 29, 2022 SDRC